Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217327 · ClinicalTrials.gov registry record
The DistaSense VITALS Study
A clinical trial of Detection of Heart Rate and Respiratory Rate, sponsored by Life Detection Technologies.
- Recruiting
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT07217327: Recruiting study of Detection of Heart Rate and Respiratory Rate, sponsored by Life Detection Technologies.
NCT07217327 is a study of Detection of Heart Rate and Respiratory Rate that is actively recruiting participants, run by Life Detection Technologies. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217327, a study of Detection of Heart Rate and Respiratory Rate, is actively recruiting participants, sponsored by Life Detection Technologies.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST DistaSense and Polysomnography
Study Locations (2)
Missouri
- Clayton Sleep Institute - St Louis
Ohio
- CTI Clinical Research Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-08-13 |
| Est. Completion | 2025-11 |
What NCT07217327 shows while recruiting
NCT07217327 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Detection of Heart Rate and Respiratory Rate appearing as the primary indexed condition, and to 1 intervention - of which DistaSense and Polysomnography is the first listed.
NCT07217327 reports a single indexed study location in Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT07217327 about?
NCT07217327 is a clinical study titled "The DistaSense VITALS Study". A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
What is the current status of trial NCT07217327?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-08-13. Estimated completion is 2025-11.
What conditions does trial NCT07217327 study?
This clinical trial studies the following conditions: Detection of Heart Rate and Respiratory Rate.
What interventions are being tested in trial NCT07217327?
The interventions under investigation include: DistaSense and Polysomnography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07217327?
This trial is sponsored by Life Detection Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217327 being conducted?
This trial has 2 study locations across Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI